Ganeden Biotech Receives “No Objection” Letter from the FDA; GanedenBC30 is First Bacillus Strain to Receive GRAS Status
(PRWeb August 02, 2012)
Read the full story at http://www.prweb.com/releases/2012/8/prweb9764949.htm
Ganeden Biotech Receives “No Objection” Letter from the FDA; GanedenBC30 is First Bacillus Strain to Receive GRAS Status
(PRWeb August 02, 2012)
Read the full story at http://www.prweb.com/releases/2012/8/prweb9764949.htm